Ramadan Intermittent Fasting Did Not Worsen Lupus Disease Activity in a Small Iranian Pilot Study: What the Research Shows

Ramadan Intermittent Fasting Did Not Worsen Lupus Disease Activity in a Small Iranian Pilot Study: What the Research Shows

Medical disclaimer: This article summarises published research for informational purposes only. It is not medical advice and is not a substitute for guidance from a qualified health professional. Always consult your doctor before starting any fasting protocol, especially if you have an existing health condition or take medication.

Study at a Glance

What This Study Looked At

Systemic lupus erythematosus (SLE) is an autoimmune disease in which flares can be triggered by physical stress, and patients are often advised to avoid prolonged fasting during religious observances like Ramadan out of caution. This Iranian pilot study asked a narrower, practical question: in patients whose lupus was already quiescent (inactive), did choosing to observe dawn-to-dusk Ramadan fasting change disease activity, immune markers, lipid profile, or quality of life compared with patients who chose not to fast? This complements broader discussions of fasting and lupus in women and the wider question of fasting in autoimmune conditions.

Who Was Studied

Participant profile: Adults with SLE in the quiescent (clinically inactive) phase of disease, recruited from the lupus unit of the Rheumatology Research Center at Tehran University of Medical Sciences between August and November 2009. Participants self-selected into fasting or non-fasting groups rather than being randomized.

Protocol: All participants were assessed at three time points — one day before Ramadan began, the day after Ramadan ended, and again three months later. At each visit, researchers measured SLE Disease Activity Index (SLEDAI) scores, anti-dsDNA antibodies, complement levels (C3), lipid profile, and health-related quality of life using the Short-Form 36 (SF-36) Health Survey.

What the Researchers Found

• Anti-dsDNA antibodies and C3 complement rose more in the fasting group than in controls, both reaching statistical significance — a laboratory-level immune shift worth noting.
• Despite those lab changes, clinical disease activity (SLEDAI) did not significantly change in the fasting group relative to controls, either immediately after Ramadan or at the 3-month follow-up.
• Quality of life (SF-36) scores were also not significantly different between fasting and non-fasting patients at any time point.
• Lipid profile changes were not reported as clinically significant between groups in the abstract-level findings.

What Did Not Change

• No flares or significant disease activity increases were reported in the fasting group during or after Ramadan.
• Quality of life did not decline in patients who chose to fast.
• The favorable laboratory shifts (rising anti-dsDNA and falling relative complement change patterns) did not translate into worse clinical outcomes within the 3-month observation window.

What the Researchers Concluded

The authors concluded that Ramadan fasting probably has no detrimental effect on disease activity or quality of life in patients with quiescent SLE, even though some immune laboratory markers (anti-dsDNA, C3) shifted more in the fasting group than in controls.

What This Means If You Fast

• This applies only to quiescent (inactive) lupus. The study population had stable, inactive disease going into Ramadan — these findings should not be extrapolated to patients with active flares or high disease activity.
• Lab markers moved, but clinical activity did not. The rise in anti-dsDNA and C3 in fasters is a signal worth monitoring, but it did not correspond to worsening SLEDAI scores or reduced quality of life in this small sample — a useful reminder that lab changes and clinical flares are not always the same thing, a theme also explored in fasting and lupus in women.
• This was self-selected, not randomized. Patients chose whether to fast, which means healthier or more confident patients may have opted into fasting — a common bias in real-world Ramadan fasting research.
• The sample is small. With only 21 fasting participants, this pilot study cannot rule out modest effects that a larger trial might detect.
• Any fasting decision with lupus should be made with a rheumatologist. Given how autoimmune flares can be triggered by physical stress, medication timing during long fasting days, hydration, and individual disease trajectory all warrant a doctor's involvement — see also the three causes of autoimmune disease in women for broader context on triggers.
• Prolonged multi-week fasting (like Ramadan) is a different exposure than daily time-restricted eating. This study evaluated roughly a month of dawn-to-dusk fasting, not a standard 16:8 or 18:6 daily pattern — the findings should not be generalized across all fasting protocols.

Study Limitations

• Small sample size (n=40 total, 21 fasting) limits statistical power and the ability to detect modest effects
• Non-randomized, self-selected design — fasting vs. non-fasting groups were not assigned, introducing potential selection bias
• Single-country, single-center study (Tehran, Iran) — results may not generalize to other populations or climates
• Only patients with quiescent disease were included, so findings say nothing about fasting during active flares
• Follow-up was limited to 3 months after Ramadan; longer-term flare risk was not assessed
• Anti-dsDNA and C3 changes reaching statistical significance without corresponding clinical change raises questions about the study's power to detect a true clinical effect either way
• Funding source not clearly reported in available abstract-level data

Source

Goharifar H, Faezi ST, Paragomi P, Montazeri A, Banihashemi AT, Akhlaghkhah M, Abdollahi B, Kamazani Z, Akbarian M. The effect of Ramadan fasting on quiescent systemic lupus erythematosus (SLE) patients' disease activity, health quality of life and lipid profile: a pilot study. Rheumatology International. 2015;35(8):1409–1414. PMID: 25972126

Frequently Asked Questions

Is it safe for someone with lupus to fast during Ramadan?

This 2015 pilot study found that in patients with quiescent (inactive) lupus, Ramadan fasting did not significantly worsen disease activity (SLEDAI scores) or quality of life over a 3-month follow-up. However, this was a small, non-randomized study of stable patients only — anyone with lupus, especially with any active disease, should discuss fasting plans with their rheumatologist before Ramadan or any extended fast.

Does fasting trigger lupus flares?

In this study, no significant flares or increases in clinical disease activity were observed in the fasting group compared to controls. Some immune laboratory markers (anti-dsDNA antibodies and C3 complement) did shift more in the fasting group, but this did not translate into worse clinical outcomes in this small sample. Larger studies are needed to confirm whether this holds broadly.

What is SLEDAI and why does it matter for fasting research?

SLEDAI (Systemic Lupus Erythematosus Disease Activity Index) is a validated clinical scoring tool used by rheumatologists to quantify how active a patient's lupus is at a given time, based on symptoms, organ involvement, and lab findings. Researchers use it as the primary way to measure whether an intervention — like fasting — makes lupus better, worse, or unchanged.

Can intermittent fasting help autoimmune conditions like lupus?

The evidence is still very limited. This study suggests fasting does not appear to harm patients with stable, quiescent lupus, but it was not designed to test whether fasting actively improves lupus. Broader research on fasting and autoimmune conditions in women explores potential immune-modulating mechanisms, but rigorous, larger trials specific to lupus are still needed.

Should I stop my lupus medication if I fast?

No. This study did not evaluate medication changes, and stopping or altering lupus medication without medical guidance can be dangerous. Any fasting protocol — Ramadan-style or otherwise — should be planned alongside your rheumatologist, particularly around medication timing, hydration, and monitoring for early flare symptoms.

Related Research and Articles

• Fasting and lupus: what women should know
• Fasting and autoimmune conditions in women
• The three causes of autoimmune disease in women
• Intermittent fasting and inflammation: the research explained
• Fasting-mimicking diet reduces MS symptoms and promotes remyelination
• Fasting and immune system regeneration (Cell Stem Cell 2014)
• Fasting and inflammation: what women should know

Want the complete guide to fasting? Get Intermittent Fasting in Practice on Amazon — and claim 3 months free on our fasting app at fastinginpractice.com/redeem.